These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21199184)

  • 21. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.
    Allen RP; Ondo WG; Ball E; Calloway MO; Manjunath R; Higbie RL; Lee MR; Nisbet PA
    Sleep Med; 2011 May; 12(5):431-9. PubMed ID: 21493132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Vivid Hallucinations Secondary to Ropinirole.
    Motin S; Mersfelder TL; Hays B
    Am J Ther; 2018; 25(6):e661-e662. PubMed ID: 26982100
    [No Abstract]   [Full Text] [Related]  

  • 26. Ropinirole for restless legs syndrome.
    Ondo W
    Mov Disord; 1999 Jan; 14(1):138-40. PubMed ID: 9918357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series.
    Dostal M; Weber-Schoendorfer C; Sobesky J; Schaefer C
    Eur J Neurol; 2013 Sep; 20(9):1241-6. PubMed ID: 23083216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D; Grunstein R; Sridhar G; Dreykluft T; Montagna P; Dom R; Lainey E; Moorat A; Roberts J
    Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data].
    Estivill E; de la Fuente V
    Rev Neurol; 1999 Nov 1-15; 29(9):805-7. PubMed ID: 10696651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to ropinirole in restless legs syndrome is independent of baseline serum ferritin.
    Morgan JC; Ames M; Sethi KD
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):964-5. PubMed ID: 18645218
    [No Abstract]   [Full Text] [Related]  

  • 31. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Giving legs to restless legs: a case study of how the media helps make people sick.
    Woloshin S; Schwartz LM
    PLoS Med; 2006 Apr; 3(4):e170. PubMed ID: 16597175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.
    Prescrire Int; 2007 Feb; 16(87):12. PubMed ID: 17323517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic Therapy for Restless Legs Syndrome/Willis-Ekbom Disease.
    Zak RS; Walters AS
    Sleep Med Clin; 2015 Sep; 10(3):279-85, xiii. PubMed ID: 26329437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless legs: do they keep you awake?
    Hutchison K; Cuevas R; Jankowiak J
    Neurology; 2004 Dec; 63(12):E21-2. PubMed ID: 15623673
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment-induced Delusions of Infestation Associated with Increased Brain Dopamine Levels.
    Fowler E; Maderal A; Yosipovitch G
    Acta Derm Venereol; 2019 Mar; 99(3):327-328. PubMed ID: 30460371
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolonged penile erection in the absence of sexual stimulation following ropinirole use for restless legs syndrome.
    Neo S; Xu Z
    Sleep Med; 2020 Apr; 68():20. PubMed ID: 32018186
    [No Abstract]   [Full Text] [Related]  

  • 38. Range of drugs associated with IFIS.
    Fine IH; Dworetzky J; Hoffman RS; Packer M
    J Cataract Refract Surg; 2009 Jan; 35(1):202. PubMed ID: 19101449
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.
    Shimo Y; Nakajima A; Hattori N
    Neurol Sci; 2015 Jun; 36(6):1021-3. PubMed ID: 25362251
    [No Abstract]   [Full Text] [Related]  

  • 40. Restless leg syndrome, dopamine agonists and sleep attacks.
    Rose AR; Antic NA; McEvoy RD
    Intern Med J; 2008 Nov; 38(11):872-3. PubMed ID: 19120542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.